GL1X · GenesisL1 explorer

Research workbench

Structure of elastase inhibitor afuei (cyrstal form I)

Analyse Structure of elastase inhibitor afuei (cyrstal form I) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3W0D
Type
protein
Length
136 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Elastase inhibitor afuei
UniProt
Q4WZ11
Pockets
1 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BElastase inhibitor afueiprotein6828% helix, 29% strandQ4WZ11

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11710.530.7929empty

Interfaces

1 interface between chains.

  • A–B · 716 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3W0D · Structure of elastase inhibitor AFUEI (cyrstal form I) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q4WZ11 · AlphaFold monomer V2.0 prediction for elastase inhibitor afuei (Q4WZ11) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.